Pharmaniaga Bhd (7081) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.28x

Pharmaniaga Bhd (7081) has a Cash Flow Reinvestment Rate of 0.28x as of December 2025, reinvesting RM27.55 Million (capex RM11.42 Million plus investments RM16.12 Million) from operating cash flow of RM98.51 Million. Check 7081 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.28x
(Capex + Investments) / Operating CF

Total Reinvested

RM27.55 Million
Capex + Investments

Operating Cash Flow

RM98.51 Million
MYR

Capital Expenditures

RM11.42 Million
MYR

Pharmaniaga Bhd Cash Flow Reinvestment Rate (2012–2024)

Historical reinvestment intensity for Pharmaniaga Bhd across 9 annual periods. Explore Pharmaniaga Bhd (7081) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Pharmaniaga Bhd (2012–2024)

Year-by-year capital reinvestment analysis for Pharmaniaga Bhd. For live market cap and broader valuation context, see Pharmaniaga Bhd stock valuation.

Year Reinvestment Rate Total Reinvested (MYR) Operating CF Capex YoY Change
2024 1.66x RM70.65 Million RM42.67 Million RM31.16 Million ▼ -45.1%
2023 3.02x RM141.60 Million RM46.95 Million RM73.66 Million ▲ +515.0%
2019 0.49x RM93.06 Million RM189.76 Million RM20.38 Million ▲ +27.8%
2017 0.38x RM91.85 Million RM239.41 Million RM29.43 Million ▼ -92.8%
2016 5.36x RM189.82 Million RM35.44 Million RM43.64 Million ▼ -38.5%
2015 8.71x RM61.00 Million RM7.00 Million RM61.00 Million ▲ +5887.6%
2014 0.15x RM31.00 Million RM213.00 Million RM31.00 Million ▼ -15.7%
2013 0.17x RM44.00 Million RM255.00 Million RM44.00 Million ▼ -87.2%
2012 1.35x RM23.00 Million RM17.00 Million RM23.00 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow